Tracers Or Tags Patents (Class 436/56)
-
Patent number: 8828729Abstract: One embodiment is a SERS enhancing substrate which includes a porous substrate and a Raman enhancing material associated with a surface of the porous substrate. The Raman enhancing material may be a Raman enhancing metal or other Raman enhancing material. The Raman enhancing material may also be configured to improve binding of a taggant to the substrate. The substrate described above may be included in a sample vessel useful for the flow-through analysis of large sample volumes, or for the rapid analysis of very dilute samples. Other embodiments include methods and systems for detecting taggants with SERS and similar techniques.Type: GrantFiled: June 4, 2012Date of Patent: September 9, 2014Assignee: Cabot CorporationInventors: Michael J. Natan, Marcelo Eduardo Piotti
-
Patent number: 8802450Abstract: Methods and compositions are provided that include a multichromophore and/or multichromophore complex for identifying a target biomolecule. A sensor biomolecule, for example, an antibody can be covalently linked to the multichromophore. Additionally, a signaling chromophore can be covalently linked to the multichromophore. The arrangement is such that the signaling chromophore is capable of receiving energy from the multichromophore upon excitation of the multichromophore. Since the sensor biomolecule is capable of interacting with the target biomolecule, the multichromophore and/or multichromophore complex can provide enhanced detection signals for a target biomolecule.Type: GrantFiled: August 1, 2011Date of Patent: August 12, 2014Assignee: Sirigen, Inc.Inventors: Brent S. Gaylord, Janice W. Hong, Tsu-Ju Fu, Cheng-Jun Sun, Russell Baldocchi
-
Patent number: 8796030Abstract: The present invention relates generally to encoding samples. More specifically, it relates to barcodes and compositions involving upconverters and methods including them. In a composition aspect of the invention, a composition comprising two or more lanthanide materials is provided. Each lanthanide material comprises a host, an absorber, and an emitter, and the materials emit detectable electromagnetic radiation upon excitation with absorbable electromagnetic energy. One or more relative ratios of emission intensities uniquely identify the composition.Type: GrantFiled: July 12, 2004Date of Patent: August 5, 2014Assignee: Parallel Synthesis Technologies, Inc.Inventor: Robert C. Haushalter
-
Patent number: 8796040Abstract: A system of quantitatively determining a biomolecule, which has: allowing fluorescent silica particles capable of emitting fluorescence detectable by a flow cytometer to capture a target biomolecule fluorescent-labelled for quantitative determination; detecting the fluorescence emitted from the fluorescent silica particles themselves by using the flow cytometer; and measuring the intensity of the fluorescence of the labelled target biomolecule, thereby quantitatively determining the target biomolecule.Type: GrantFiled: August 22, 2008Date of Patent: August 5, 2014Assignees: The Furukawa Electric Co., Ltd., The University of TokushimaInventors: Hideki Aizawa, Michio Ohkubo, Michihiro Nakamura, Hirokazu Miyoshi
-
Publication number: 20140205749Abstract: A detectable taggant is described. The detectable taggant may include at least one nano-antenna having a resonant frequency of about 300 GHz to about 800 THz. The nano-antenna is adapted to be physically or chemically associated with an article of manufacture.Type: ApplicationFiled: August 14, 2012Publication date: July 24, 2014Applicant: EMPIRE TECHNOLOGY DEVELOPMENT LLCInventor: Christopher J. Rothfuss
-
Patent number: 8778624Abstract: Hydrophilic, chemiluminescent acridinium compounds containing zwitterions are disclosed. These acridinium compounds, when used as chemiluminescent labels in immunochemistry assays and the like, exhibit decreased non-specific binding to solid phases and provide increased assay sensitivity.Type: GrantFiled: November 12, 2010Date of Patent: July 15, 2014Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Anand Natrajan, David Sharpe, Qingping Jiang
-
Patent number: 8778694Abstract: Provided herein are batch methods and devices for enriching trace quantities of impurities in gaseous mixtures, such as hydrogen fuel. The methods and devices rely on concentrating impurities using hydrogen transport membranes wherein the time period for concentrating the sample is calculated on the basis of optimized membrane characteristics, comprising its thickness and permeance, with optimization of temperature, and wherein the enrichment of trace impurities is proportional to the pressure ratio Phi/Plo and the volume ratio V1/V2, with following detection of the impurities using commonly-available detection methods.Type: GrantFiled: July 13, 2010Date of Patent: July 15, 2014Assignee: Uchicago Argonne, LLCInventors: Shabbir Ahmed, Sheldon H. D. Lee, Romesh Kumar, Dionissios D. Papadias
-
Patent number: 8765484Abstract: The invention concerns a particle having a code embedded in its physical structure by refractive index changes between different regions of the particle. In preferred embodiments, a thin film possesses porosity that varies in a manner to produce a code detectable in the reflectivity spectrum.Type: GrantFiled: January 31, 2003Date of Patent: July 1, 2014Assignee: The Regents of the University of CaliforniaInventors: Michael J. Sailor, Thomas Schmedake, Frederique Cunin, Jamie Link
-
Patent number: 8765391Abstract: A method and kit for assaying a cell sample for the presence of at least a threshold number of cells of a given type are disclosed. The kit includes an assay device having a sample chamber for receiving the cell sample and an elongate collection chamber containing a selected-density and/or viscosity medium and having along its length, a plurality of cell-collection regions, and particles which are capable of specific attachment to cells of the selected cell type, and which are effective, when attached to the cells, to increase the density or magnetic susceptibility of the cells. In operation, particle-bound cells and particles in the cell sample are drawn through the elongate collection chamber under the influence of a gravitational or selected centrifugal or magnetic-field force until the particle-bound cells and particles completely fill successive cell-collection regions in the collection chamber.Type: GrantFiled: August 20, 2010Date of Patent: July 1, 2014Assignee: Zyomyx, Inc.Inventors: Frank Zaugg, Renee Tobias, Silvia McManus-Munoz, Peter Kernen, Laurence Ruiz-Taylor, Peter Wagner
-
Patent number: 8765392Abstract: The present invention relates to methods and kits for diagnosing, ascertaining the clinical course of myelodysplastic syndrome (MDS) and ascertaining response to a therapy regimen of myelodysplastic syndrome. Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with MDS based on surface markers unique to MDS.Type: GrantFiled: January 11, 2013Date of Patent: July 1, 2014Assignee: The Trustees of the University of PennsylvaniaInventors: Jonni Moore, Sundhu Cherian, Adam Bagg
-
Publication number: 20140179009Abstract: The invention relates to a mineral wool product comprising mineral fibers that is marked with an UV or IR active substance and can therefore be identified under exposure to suitable radiation.Type: ApplicationFiled: February 27, 2014Publication date: June 26, 2014Applicant: Knauf InsulationInventors: Markus Mente, Stefan Kossler
-
Patent number: 8759115Abstract: An assay device for performing an assay on a liquid sample using a detection conjugate capable of binding to an antigen and containing a label. The device includes a substrate surface having a sample addition zone, a reaction zone and an absorbing zone, the zones being connected by at least one fluid passage, wherein the device has a first functionality verifying feature located between the sample addition zone and the reaction zone, and a second functionality verifying feature located within the absorbing zone. Both functionality verifying features are capable of undergoing a detectable change when contacted by the sample, in which the assay device further includes at least one alignment verification zone. There is further provided a kit of parts and a method of conducting an assay.Type: GrantFiled: December 12, 2012Date of Patent: June 24, 2014Assignee: Johnson & Johnson ABInventors: Per Ove Ohman, Ib Mendel-Hartvig, Tomas Lindstrom
-
Patent number: 8753889Abstract: Methods are disclosed for using stable isotopes of carbon and nitrogen in hair and feces to predict disease in animals such as predicting the susceptibility of dairy cows to periparturient production-related metabolic diseases (PRMDs). Other methods that are disclosed are for using stable isotopes of carbon and nitrogen in blood components, erythrocytes and plasma proteins, to predict dairy cow susceptibility to PRMDS; yet other disclosed methods are for using stable isotopes of carbon and nitrogen in hair and feces of horses as a prognostic indicator after surgical or medical correction of gastrointestinal colic. Other methods that are disclosed also include using stable isotopes of carbon and nitrogen in blood components, erythrocytes and plasma proteins, of horses as a prognostic indicator before or after surgical or medical correction of gastrointestinal colic.Type: GrantFiled: April 1, 2011Date of Patent: June 17, 2014Inventor: Beverly L. Roeder
-
Publication number: 20140154670Abstract: A fluid delivery system may include a container that houses a medical fluid, a fluid pressurizing unit, and a fluid transfer set that transfers the medical fluid from the container to the fluid pressurizing unit. To validate the integrity and sterility of the fluid delivery system, the system may undergo testing protocols to evaluate the susceptibility of the system to pathogenic ingress, chemical degradation, and/or fluid cross-contamination between patient fluid delivery procedures. The testing protocols may help ensure that delivery system components used during multiple different fluid delivery procedures perform as well as if the components were replaced after each fluid delivery procedure.Type: ApplicationFiled: December 5, 2013Publication date: June 5, 2014Applicant: Bracco Imaging S.p.AInventors: Robert C. Williams, JR., Patrice Marchildon
-
Publication number: 20140154671Abstract: A fluid delivery system may include a container that houses a medical fluid, a fluid pressurizing unit, and a fluid transfer set that transfers the medical fluid from the container to the fluid pressurizing unit. To validate the integrity and sterility of the fluid delivery system, the system may undergo testing protocols to evaluate the susceptibility of the system to pathogenic ingress, chemical degradation, and/or fluid cross-contamination between patient fluid delivery procedures. The testing protocols may help ensure that delivery system components used during multiple different fluid delivery procedures perform as well as if the components were replaced after each fluid delivery procedure.Type: ApplicationFiled: December 5, 2013Publication date: June 5, 2014Applicant: Bracco Imaging S.p.AInventors: Robert C. Williams, JR., Patrice Marchildon
-
Patent number: 8716024Abstract: A method of distinguishing a control solution from a sample in an electrochemical test sensor is performed. The method includes adding a control marker to the control solution. The control solution includes the control marker and analyte. The test sensor includes working and counter electrodes, and a reagent. A potential is applied to the test sensor to oxidize the control marker and the analyte. The resulting electrical current is measured. A potential is applied to the test sensor lower than the other potential in which the potential is sufficient to oxidize the analyte and not the control marker. The resulting electrical current is measured. Determining whether a control solution or a sample is present based on the measured electrical currents. To increase the measured current, a salt may be added to the control solution in an amount sufficient to increase the electrical current by at least 5% as compared to a control solution in the absence of a salt.Type: GrantFiled: November 20, 2012Date of Patent: May 6, 2014Assignee: Bayer HealthCare LLCInventors: Jing Lin, Fu Hsiung Tsai, Huan-Ping Wu, Nicole D. Ellis, Henry C. Arndt
-
Patent number: 8716027Abstract: A nucleic acid tag comprising a nucleotide-support platform attached to a nucleic acid molecule, an odorant, and an encapsulant. Unique nucleic acid-containing tags containing an odorant are seeded at one or more geographic locations. Using odorant-detection systems, the person or object of interest is examined for the presence of one or more of the odorant, thereby revealing the presence of the seeded nucleic acids and eliminating the expense and time associated with unnecessary screening. The geographic location associated with each detected nucleic acid is used to backtrack the item's path or extrapolate a probable point of origin.Type: GrantFiled: August 3, 2010Date of Patent: May 6, 2014Assignee: SRC, Inc.Inventor: Mary F. Bronchetti
-
Publication number: 20140120626Abstract: Method of marking a hydrocarbon liquid includes adding to the liquid, a tracer compound of Formula I or II: wherein at least one of R1-R6 in Formula I and at least one of R7-R14 in Formula II is selected from: i. a bromine or fluorine atom; ii. a partially or fully halogenated alkyl group; iii. a branched or cyclic C4-C20 alkyl group; iv. an aliphatic substituent linking two positions selected from R1-R6 in Formula I to one another or two positions selected from R7-R14 in Formula II to one another; or v. a phenyl group substituted with a halogen atom, an aliphatic group or halogenated aliphatic group and none of R1-R6 and none of R7-R14 being a sulphonate group or COOR15, where R15 represents H, C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, C3-C15 cycloalkyl or aryl.Type: ApplicationFiled: May 9, 2012Publication date: May 1, 2014Applicant: JOHNSON MATTHEY PUBLIC LIMITED COMPANYInventors: David Stubbs, Duncan William John McCallien
-
Patent number: 8703493Abstract: A nucleic acid tag comprising a nucleotide-support platform attached to a nucleic acid molecule, a fire retardant, and an encapsulant. Unique nucleic acid-containing tags containing a fire- or heat-protective element are seeded at one or more geographic locations. Using sequence analysis techniques, the person or object of interest is examined for the presence of one or more of the seeded nucleic acids. The geographic location associated with each detected nucleic acid is used to backtrack the item's path or extrapolate a probable point of origin.Type: GrantFiled: June 15, 2010Date of Patent: April 22, 2014Assignee: SRC, Inc.Inventors: Mary F. Bronchetti, Laura T. Bortolin
-
Patent number: 8697450Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.Type: GrantFiled: March 5, 2013Date of Patent: April 15, 2014Assignee: PerkinElmer Health Sciences, Inc.Inventors: Blas Cerda, Alex Cherkasskiy
-
Publication number: 20140087473Abstract: A method of marking a hydrocarbon liquid includes the step of adding to the liquid, as a tracer compound, a compound of Formula I: wherein at least one of R1-R4 is selected from: i. a bromine or fluorine atom; ii. a partially or fully halogenated alkyl group; iii. a branched or cyclic C4-C20 alkyl group; iv. an aliphatic substituent linking two positions selected from R1-R4 in Formula I to one another; or v. a phenyl group substituted with a halogen atom, an aliphatic group or halogenated aliphatic group. The tracer compounds are resistant to removal from the fuel by chemical laundering or by contact with absorbents such as charcoal.Type: ApplicationFiled: May 9, 2012Publication date: March 27, 2014Inventors: Duncan Mccallien, Vincent Brian Croud
-
Patent number: 8673554Abstract: Disclosed are methods useful in multiplex cell-based assays for compound screening employing imaging instrumentation. The methods described herein offer high content information relating to the biological potency of test agents, off-target effects and cellular toxicity of potential drug candidates.Type: GrantFiled: January 15, 2009Date of Patent: March 18, 2014Assignee: Ge Healthcare UK LimitedInventor: Jeffrey K. Horton
-
Patent number: 8642346Abstract: At least one of these or other problems is reduced using a building material that is uniquely identifiable. A method of making an identifiable gypsum-based building product includes selecting a tagging material occurring naturally in a component of the building material and choosing a carrier substance having a high concentration of the tagging material. By selecting an amount of the carrier substance and adding it to the building material, a building product having a unique product characteristic is created. In a second embodiment of the invention, a second tagging material is combined with the first tagging material to create a unique product. In yet another embodiment of the invention, a supplemental amount of the tagging material is added to the gypsum-based composition in addition to the carrier substance. Some tagging materials are useful in a gypsum-based composition to produce a visual confirmation of the presence of the tagging material.Type: GrantFiled: June 1, 2011Date of Patent: February 4, 2014Assignee: United States Gypsum CompanyInventors: Salvatore C. Immordino, Jr., Brett R. Link, Charles J. Miller, Guy L. Rosenthal, Richard B. Stevens, Lee K. Yeung
-
Patent number: 8637327Abstract: The invention relates to a method for optimizing the automatic fluorescence pattern recognition in immunodiagnosis. In this method, in addition to or together with the fluorescence dye, one or more other indicator dyes for the identification of relevant structures are incubated before an image is taken with a camera.Type: GrantFiled: June 1, 2007Date of Patent: January 28, 2014Assignee: Euroimmun Medizinische Labordiagnostika AGInventors: Stöcker Winfried, Hendrik Fauer, Christopher Krause, Erhardt Barth, Thomas Martinetz
-
Patent number: 8628977Abstract: Reagents and methods are provided that permit simultaneous analysis of multiple diverse small molecule analytes present in a complex mixture. Samples are labeled with chemically identical but isotopically distinct forms of the labeling reagent, and analyzed using mass spectrometry. A single reagent simultaneously derivatizes multiple small molecule analytes having different reactive functional groups.Type: GrantFiled: May 1, 2009Date of Patent: January 14, 2014Assignee: Purdue Research FoundationInventors: Jiri Adamec, Wen-Chu Yang, Fred E. Regnier
-
Patent number: 8617901Abstract: A comprehensive approach for interpretation of the multiple spiking isotope dilution results is described herein. It has now been found that a method of multiple spiking isotope dilution analysis for mass spectrometry is possible using an approach that permits precise and simultaneous characterization of m substances from a sample even if species inter-conversion (degradation and formation) has occurred prior to separation. Advantageously, initial and final amounts of involved analytes, conversion extent, conversion degree and rate constants from the results of a single quantitation experiment may be obtained with the present method. In a particularly advantageous embodiment, uncertainty in the characterization of the substances may be estimated more accurately by also estimating increase in the uncertainty due to inter-conversion of the analytes.Type: GrantFiled: November 18, 2009Date of Patent: December 31, 2013Inventors: Laurent Ouerdane, Juris Meija, Zoltan Mester
-
Patent number: 8609421Abstract: The present invention is generally directed to compositions, methods, and systems for performing single-molecule, real-time analysis of analytical reactions in which protein synthesis is occurring. The ability to analyze such reactions provides an opportunity to study those reactions as well as to potentially identify factors and/or approaches for impacting such reactions, e.g., to either enhance, inhibit, or otherwise affect such reactions including, but not limited to, affecting the reaction rate, processivity, fidelity, duration, and the like.Type: GrantFiled: June 11, 2010Date of Patent: December 17, 2013Assignee: Pacific Biosciences of California, Inc.Inventors: Benjamin Flusberg, Stephen Turner, Jonas Korlach, Eric Schadt
-
Patent number: 8603827Abstract: A tracer system comprising a tracer compound for a fluid system, the tracer compound comprising one or more polyether alcohol compounds. The one or more polyether alcohol compounds is arranged for being placed in contact with a first part of said fluid system. The one or more polyether alcohol compounds is truly monodisperse. The polyether alcohol compounds comprises one or more functional groups. The one or more truly monodisperse polyether alcohol compounds is arranged for being detected in a second part of the fluid system in fluid communication with said first part of said fluid system. The tracer compound is detectable in very low concentrations.Type: GrantFiled: July 10, 2009Date of Patent: December 10, 2013Assignee: Resman ASInventors: Kolbjørn Zahlsen, Lars Kilaas
-
Patent number: 8592216Abstract: The present invention provides methods for enhancing the fragmentation of peptides for mass spectrometry by modifying the peptides with a tagging reagent containing a functional group, such as a tertiary amine, having a greater gas-phase basicity than the amide backbone of the peptide. These high gas-phase basicity functional groups are attached to a peptide by reacting the tagging reagent to one or more available carboxylic acid groups of the peptide. Linking these high gas-phase functional groups to the peptides leads to higher charge state ions from electrospray ionization mass spectrometry (ESI-MS), which fragment more extensively during fragmentation techniques, particularly non-ergodic fragmentation techniques such as electron capture dissociation (ECD) and electron transfer dissociation (ETD).Type: GrantFiled: April 14, 2010Date of Patent: November 26, 2013Assignee: Wisconsin Alumni Research FoundationInventors: Brian L. Frey, April L. Jue, Casey J. Krusemark, Lloyd M. Smith, Joshua J. Coon
-
Patent number: 8592213Abstract: A first fuel and a second fuel are marked with a marker that can be detected quantitatively in a predetermined concentration range. The second fuel is marked with a binary marker. Decreased concentration of the quantitative marker, presence of a binary marker, or both may be indicative of a fuel that is altered (e.g., mixed, laundered, diluted, or adulterated). Testing a fuel includes testing the fuel for a presence of a first marker in the fuel in a predetermined concentration range, and testing the fuel for a presence of a second marker. The presence of the first marker in the predetermined concentration range and an absence of the second marker may be indicative that the fuel is unaltered. The presence of the first marker in the fuel in a concentration less than the predetermined concentration range or the presence of the second marker may be indicative that the fuel is altered.Type: GrantFiled: April 1, 2011Date of Patent: November 26, 2013Assignee: Authentix, Inc.Inventors: Timothy G. Wilkinson, Erwin Dorland
-
Patent number: 8574859Abstract: The present invention generally provides methods and systems for performing in vivo flow cytometry by using blood vessels as flow chambers through which flowing cells can be monitored in a live subject in vivo without the need for withdrawing a blood sample. In some embodiments, one or more blood vessels are illuminated with radiation so as to cause a multi-photon excitation of an exogenous fluorophore that was previously introduced into the subject to label one or more cell types of interest. In some other embodiments, rather than utilizing an exogenous fluorophore, endogenous (intrinsic) cellular fluorescence can be employed for in vivo flow cytometry. The emission of fluorescence radiation from such fluorophores in response to the excitation can be detected and analyzed to obtain information regarding a cell type of interest.Type: GrantFiled: March 27, 2009Date of Patent: November 5, 2013Assignee: The General Hospital CorporationInventors: Charles P. Lin, Alicia L. Carlson, Clemens Alt, David P. Biss, Costas M. Pitsillides, Chunqiang Li
-
Patent number: 8546092Abstract: An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population.Type: GrantFiled: December 7, 2009Date of Patent: October 1, 2013Assignee: University of CalcuttaInventors: Suryyani Deb, Anjan Dasgupta, Prabir Lahiri
-
Patent number: 8536520Abstract: A method for identifying a biological analyte that is affected by a stressor is disclosed in which two substantially identical biological samples are provided, with a first sample being a control sample and a second sample being an experimental sample. The control sample is grown with a nutrient having an isotope of a first atom, whereas the experimental sample is grown with a nutrient having a second isotope of the first atom. The experimental sample is grown with a stressing agent and regimen. The samples are admixed, and the formed composite is mass spectroscopically assayed for analyte peaks. The ratio of first isotope to second isotope is determined for the peaks, as is a sample median isotopic ratio. The ratio for assayed analyte peaks is compared with the median ratio. An analyte whose isotopic ratio significantly deviates from the median ratio is an analyte affected by the stressing agent.Type: GrantFiled: October 25, 2010Date of Patent: September 17, 2013Assignee: IROA Technologies LLCInventor: Christopher William Ward Beecher
-
Patent number: 8529846Abstract: A system, method and apparatus in the detection of a scent to locate the damage and its extent and to aid in the repair manually or self-repair.Type: GrantFiled: October 26, 2011Date of Patent: September 10, 2013Assignee: The United States of America as Represented by the Department of NavyInventor: Michael E. Wright
-
Patent number: 8524505Abstract: The present invention provides a blood analyzer and a blood analyzing method capable of obtaining information regarding B lymphocytes and T lymphocytes without using a fluorescence-labeled antibody. The blood analyzer of the present invention includes a blood specimen supplying portion, a sample preparation portion that prepares a measurement sample without using a fluorescence-labeled antibody by mixing a blood specimen supplied from the blood specimen supplying portion, a hemolyzing agent, and a fluorescent dye that stains nucleic acid, a light source, a first detector that detects fluorescence, a second detector that detects scattered light, and information processing portion that classifies lymphocytes based on the intensity of fluorescence and scattered light, and based on the fluorescence intensity of the classified lymphocytes, obtains information regarding B-lymphocytes and T-lymphocytes.Type: GrantFiled: June 30, 2010Date of Patent: September 3, 2013Assignee: Sysmex CorporationInventors: Mari Kono, Yuri Takagi, Shoichiro Asada
-
Patent number: 8520205Abstract: A method and apparatus is disclosed for detecting, classifying and identifying airborne and non-airborne particles on an individual basis in substantially real time by directing a particle stream to react with optical reporters and markers and then exposing the stream to an excitation source such that individual particles have their multiple identifying characteristics detected.Type: GrantFiled: February 9, 2006Date of Patent: August 27, 2013Assignee: Flir Systems, Inc.Inventor: David B. Silcott
-
Patent number: 8518703Abstract: A system, method and apparatus in the detection of a scent to locate the damage and its extent and to aid in the repair manually or self-repair. A method for detecting damage in a device including, providing at least one first microcapsule having at least two scents in a composition detectable by a machine, human, and/or animal or any combination thereof, associating the scent(s), where the scent(s) is a device, releasing the scent(s) when damage has occurred to the device, and detecting the scent(s) to alert a detector of the damage and level of the damage.Type: GrantFiled: October 27, 2011Date of Patent: August 27, 2013Assignee: The United States of America as Represented by the Secretary of the NavyInventor: Michael E. Wright
-
Patent number: 8501481Abstract: A system and method for tagging, tracking, locating and identifying people and vehicles transporting people using Perfluorocarbon tracers. An on-going problem faced by military as well as law enforcement personnel is that of friendly fire incidents. To prevent possible friendly-fire incidents, troops would separate the two layers of the uniform patch, thereby releasing a controlled release of the Perfluorocarbon vapors. Other “friendly” troops, equipped with sensors tuned to the specific perfluorocarbon characteristics would thus be able to literally view a plume around the tagged person or object. The system may conversely be used to tag enemies. Formulations of mixed perfluorocarbons may be used to provide coding of emissions.Type: GrantFiled: April 9, 2012Date of Patent: August 6, 2013Assignee: Tracer Detection Technology Corp.Inventor: Jay Fraser
-
Patent number: 8497131Abstract: Surface Enhanced Spectroscopy-Active Composite Nanoparticles (SACN) comprising: core/shell nanoparticles comprising nanoparticle cores covered with shells, wherein the cores and the shells may comprise the same or different materials; at least one Raman-active reporter molecule associated with said core/shell nanoparticle; and an SiO2 encapsulant which encapsulates the core/shell nanoparticle and the at least one Raman-active reporter molecule, are described.Type: GrantFiled: April 25, 2005Date of Patent: July 30, 2013Assignee: Becton, Dickinson and CompanyInventors: Michael J. Natan, Sharron Gaynor Penn, R. Griffith Freeman, Gabriela Chakarova, William E. Doering, Ian D. Walton
-
Patent number: 8481322Abstract: A method for marking a petroleum hydrocarbon, biodiesel fuel or ethanol fuel by adding to the petroleum hydrocarbon, biodiesel fuel or ethanol fuel at least one compound having formula (I) wherein R1 and R2 independently represent at least one substituent selected from the group consisting of hydrogen, C1-C12 alkyl, C1-C12 alkoxy and nitro; and R3 and R4 independently represent hydrogen, methyl or ethyl.Type: GrantFiled: May 23, 2011Date of Patent: July 9, 2013Assignee: ANGUS Chemical CompanyInventors: George David Green, Raymond John Swedo
-
Patent number: 8465981Abstract: The presently-disclosed subject matter provides biosensors for detecting molecules of interest. The biosensors include a polypeptide capable of selectively-binding glucose, wherein the polypeptide molecule is selected from: an unnatural analogue of wild type glucose binding protein; a fragment of wild type glucose binding protein; and an unnatural analogue fragment of wild type glucose binding protein.Type: GrantFiled: August 6, 2008Date of Patent: June 18, 2013Assignee: University of Kentucky Research FoundationInventors: Sylvia Daunert, Kendrick Turner, Smita Joel, Laura Rowe
-
Patent number: 8465988Abstract: Methods are provided herein for determining antioxidant activity of a test sample in intact cells. The method includes determining the antioxidant capacity of a test sample in intact red blood cells, wherein the test sample is added to intact red blood cells and oxidative damage is measured by alteration of fluorescence intensity of an oxidation-sensitive fluorescent indicator dye.Type: GrantFiled: October 31, 2008Date of Patent: June 18, 2013Assignee: Natural Immune Systems, Inc.Inventor: Gitte S. Jensen
-
Patent number: 8455257Abstract: A system for automatically testing a fluid specimen to indicate the presence of specified chemical components in the specimen. The system utilizes an assaying device having a collection cup and a cap that carries at least one test strip. The device includes an integrated aliquot delivery mechanism actuatable to wet the test strip with an aliquot delivered from the fluid specimen. The assaying device operates in conjunction with an electronic reader device capable of actuating the aliquot delivery mechanism and reading the reaction of the test strip. A reader device defines a keyed receptacle for accommodating a complementary shaped cup housing in a particular orientation. The reader device includes a camera for capturing the image of a test strip, an actuator for actuating an aliquot delivery mechanism, and a microprocessor/controller for (1) controlling the camera and actuator and (2) processing the image.Type: GrantFiled: May 23, 2012Date of Patent: June 4, 2013Assignee: eScreen, Inc.Inventors: Murray I. Lappe, David A. Birkner, John W. Goodin, Keith Patten, Bill Whitford
-
Patent number: 8445291Abstract: Provide is a method for detecting a target substance, which method can visualize the expression of the target substance at any time point while reducing influences on the functions of the target substance, can use fluorescent dyes having various excitation/emission wavelengths, and can achieve easy staining process. Also provided are a tag, a DNA, a vector, a probe and a detection kit suitable for use in the above-described detection method. Specifically, the method for detecting a target substance, comprises the steps of bringing into contact with each other (a) a tag comprising a polypeptide forming an ?-helix structure, the tag bound to the target substance, and (b) a probe comprising a compound bound to a fluorescent dye; and measuring the fluorescence emitted by the fluorescent dye. The binding of the tag ?-helix structure to the probe compound induces a spectral change in the fluorescence emitted by the fluorescent dye.Type: GrantFiled: September 22, 2009Date of Patent: May 21, 2013Assignee: National University Corporation Tokyo Medical and Dental UniversityInventors: Hirokazu Tamamura, Hiroshi Tsutsumi
-
Patent number: 8431416Abstract: Chemically-reactive, water-soluble, heterocycle-substituted 7-hydroxycoumarin dyes, their bioconjugates and uses are described. The conjugates derived from reactive heterocycle-substituted 7-hydroxycoumarin dyes are used for analyzing biological compounds. These heterocycle-substituted 7-hydroxycoumarin dyes are particularly useful as fluorescent labels for biopolymer detection reagents, such as antibodies or nucleic acid probes. The dye-antibody conjugates of the invention are particularly useful for analyzing analytes using a flow cytometer equipped with a violet laser as an excitation source due to their strong absorption at 405 nm and high fluorescence quantum yield.Type: GrantFiled: March 17, 2010Date of Patent: April 30, 2013Assignee: Becton, Dickinson and CompanyInventors: Zhenjun Diwu, Timothy Dubrovsky, Barnaby Abrams, Jinfang Liao, Qinglin Meng
-
Patent number: 8426143Abstract: The present invention comprises novel analogs of gemcitabine and novel gemcitabine immunogens leased out of, i.e., derived from, the 5?-hydroxy position of gemcitabine. The invention also comprises unique monoclonal antibodies generated using gemcitabine linked immunogens as well as unique conjugates and tracers which antibodies, conjugates, and tracers are useful in immunoassays for the quantification and monitoring of gemcitabine in biological fluids.Type: GrantFiled: May 24, 2011Date of Patent: April 23, 2013Assignee: Saladax Biomedical Inc.Inventors: Salvatore J. Salamone, Jodi Blake Courtney, Howard Sard, Christopher Spedaliere
-
Patent number: 8420406Abstract: Described is a method for analyzing the metabolites of a biological sample which comprises quantitatively determining one or more metabolites in said sample in a way that said quantitative determination resolves isotopic mass differences within one metabolite, said method being characterized in that the sample comprises or is derived from a cell which has been maintained under conditions allowing the uptake of an isotopically labeled metabolizable compound so that the metabolites in said cell are saturated with the isotope with which said metabolizable compound is labeled. This method may further comprise, prior to quantitative determining the metabolites, combining the biological sample (i.e. the first biological sample) with a second biological sample in which the metabolites are not isotopically labeled or are isotopically labeled differently from the first biological sample; and determining in said biological samples the relative quantity of metabolites which differ by their isotopical label.Type: GrantFiled: December 17, 2004Date of Patent: April 16, 2013Assignee: Max-Planck-Gessellschaft zur Forderung der Wissenschaften E.V.Inventors: Alexander Lüdemann, Alexander Erban, Cornelia Wagner, Joachim Kopka
-
Patent number: 8415161Abstract: The present invention reagents and methods for setting up an instruments having a multiplicity of detector channels for analyzing a multiplicity of fluorescent dyes. The present invention is particularly applicable in the field of flow cytometry.Type: GrantFiled: November 10, 2009Date of Patent: April 9, 2013Assignee: Becton, Dickinson and CompanyInventors: Ming Yan, Alan M. Stall, Joseph T. Trotter, Robert A. Hoffman
-
Patent number: 8415173Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: August 26, 2011Date of Patent: April 9, 2013Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman
-
Patent number: RE44859Abstract: Method as well a kit for the performance of the method for the investigation of biological samples from a mammal for at least one component, wherein the method includes the following steps: (a) Administering at least one marker substance to a mammal; (b) Waiting for a length of time which is sufficient for the at least one marker substance to reach the location of sample removal; (c) Removing a biological sample from the mammal; (d) Investigating the biological sample for the presence and/or amount of at least one marker substance or a derivative thereof; and, if the at least one marker substance or the derivative thereof is detectable in the biological sample; (e) Investigating the biological sample for an analyte.Type: GrantFiled: August 22, 2012Date of Patent: April 22, 2014Inventors: Ruprecht Keller, Gisela Gauchel